Cantor Fitzgerald Reiterates Neutral on Humana, Maintains $360 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated a Neutral rating on Humana (NYSE:HUM) and maintained a price target of $360.
July 23, 2024 | 4:25 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Cantor Fitzgerald analyst Sarah James has reiterated a Neutral rating on Humana and maintained a price target of $360.
The reiteration of a Neutral rating and maintenance of the $360 price target suggests that the analyst does not foresee significant short-term changes in Humana's stock price. This neutral stance indicates stability rather than a bullish or bearish outlook.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100